Gene-Disorder Association · Article
Gene
LPLLipoprotein Lipase
×
First reported
1990
Supporting publications
30
Manually curatedApproved treatment annotated
Association Review
In brief
The association between LPL (Lipoprotein Lipase) and Lipid Metabolism Disorder is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
0
Compounds
1
Trials
13of 162 via LPL compounds
Publications
30
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Lipid Metabolism Disorder
The disorder
10 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Mechanism overlap
Shared mechanisms
1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
06
Interventions
Therapeutics
1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
162 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
30 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
15 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access